Feb 16, 2022 / 01:30PM GMT
Operator
Good morning. My name is Lydia, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Blueprint Medicines Fourth Quarter and Full Year 2021 Financial Results Conference Call. (Operator Instructions)
Kristin Hodous, you may begin your conference.
Kristin Hodous - Blueprint Medicines Corporation - Senior Manager of IR
Thank you, operator. Good morning, everyone, and welcome to Blueprint Medicines Fourth Quarter and Full Year 2021 Financial and Operating Results Conference Call. This morning, we issued a press release, which outlines the topics we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.
Today, on our call, Jeff Albers, our Chief Executive Officer; and Kate Haviland, our Chief Operating Officer, will discuss Blueprint Medicines' fourth quarter 2021 business highlights; Christy Rossi, our
Q4 2021 Blueprint Medicines Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
